Sami Ellouze

Sami Ellouze is the Director, France General Manager at HiFiBiO. Prior to this, they were a Senior Research Associate at hifibio - high fidelity biology from May 2016 to October 2017. From August 2014 to May 2016, they were an Ingà nieur biotechnologie at hifibio. Sami has also worked as an assistant ingà nieur at ifp energies nouvelles from March 2012 to April 2012, and as an Ingà nieur d'à tude en technique biologique at ics igbmc from July 2014 to August 2014.

From March 2014 to June 2014, Sami Ellouze worked as an ingà nieur next-generation sequencing at inserm ircm. Sami also organized ngs workshops at inserm ircm from September 2013 to June 2014. From September 2013 to February 2014, they worked as an ingà nieur stagiaire next-generation sequencing.

Sami Ellouze has also worked on the development of scfv solubles from the phagic vector pak100 as part of their mise au point de l'expression de scfv solubles à partir du vecteur phagique pak100 project at utc from February 2013 to March 2013. Sami has also worked as a stage assistant ingà nieur at laberca from September 2011 to February 2012, and as a chef de projet 'mà thode d'analyse des prà curseurs des s

Sami Ellouze was educated at lycée sophie - barat, paris - sud university (paris xi), and université de technologie de compiègne (utc).

Their manager is Liang Schweizer, Co-Founder, Chairman & CEO. They are on a team with Jinping Gan - Executive Director & Global Head, Antibody Discovery & Optimization, Francisco Adrian - Chief Scientific Officer, and Andreas Raue - Executive Director & Global Head, Drug Intelligent Science.